The pharmaceutical industry has withdrawn from the ‘antibiotic space.’ Is it time for research universities to step in?

Biomedical engineering researchers have developed a drug delivery system consisting of nanoscale “cocoons” made of DNA that target cancer cells and trick the cells into absorbing the cocoon before unleashing anticancer drugs. The work was done by researchers at North Carolina State University and the University of North Carolina at Chapel Hill.

A Kansas State University professor is researching ways to keep animals and humans safe from tick-borne diseases.

Scientists at Benaroya Research Institute at Virginia Mason (BRI) recently received a $2.2 million grant from the National Institutes of Health to find a unique biomarker that initiates and drives allergies. This grant expands on previous discoveries that led to the isolation of a type of white blood cells that show up only in people with allergic disease. 

A new technique makes it possible to quickly detect the presence of drugs or to monitor certain medical conditions using only a single drop of blood or urine, representing a potential tool for clinicians and law enforcement.

Problem: In recent years, cell biology has included more emphasis on the study of rapid movement inside live cells: its dynamics, mechanisms, electrochemical signaling and protein transport. To capture these events while avoiding image artifacts, frame rates must be high enough to accurately sample these cellular phenomena. Depending on the event, these rates can range from 20 to several thousand frames per second with exposure times well below 100ms.

Salk scientists find that a vitamin D-derivative makes tumors vulnerable to chemotherapy.

This is the inescapable conclusion of Michael Kinch’s adventures in data mining

Findings from two newly published papers may help provide a design for new anticancer tactics.

After 12 years of hosting the annual Ion Channel Retreat in Vancouver, Aurora Biomed is expanding its global reach to include a second retreat in Guangzhou, China.

By tracking down how bacterial defense systems work, the scientists can potentially fight infectious diseases and genetic disorders.

In the race to find more effective ways to treat cancer, Boise State University biophysicist Daniel Fologea is working outside the rules of general mathematics that say one plus one equals two. In his world, one plus one adds up to a whole lot more.